0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover346.24%IV-84.50%PremiumAug 16, 2024Expiry Date4.58Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5856Delta0.0794Gamma0.99Leverage Ratio-0.0374Theta-0.0048Rho-0.58Eff Leverage0.0056Vega
Prime Medicine Stock Discussion
Down -12%
Net Inflow 154.87
XL in 136.33
XL out 0
$Prime Medicine(PRME.US)$ $NVIDIA(NVDA.US)$
• Editing Genes | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• Creating Therapies | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• Building DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• Dis...
NEWS
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
No comment yet